Mayne Financial Statements From 2010 to 2026

Pink Sheets . USA . 
Stock . Mayne Pharma Group
MAYNF Stock  USD 2.01  0.07  3.37%   
Mayne Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mayne Pharma's valuation are provided below:
Mayne Pharma Group does not presently have any fundamental ratios for analysis.
Check Mayne Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mayne Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mayne financial statements analysis is a perfect complement when working with Mayne Pharma Valuation or Volatility modules.
  
This module can also supplement various Mayne Pharma Technical models . Check out the analysis of Mayne Pharma Correlation against competitors.

Currently Active Assets on Macroaxis

HITIHigh Tide
HITIHigh Tide
BACBank of America
SSentinelOne
GMGeneral Motors

Other Information on Investing in Mayne Pink Sheet

Mayne Pharma financial ratios help investors to determine whether Mayne Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mayne with respect to the benefits of owning Mayne Pharma security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY